Variant report
Variant | nsv971170 |
---|---|
Chromosome Location | chr7:38071251-38078396 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:38076665..38079427-chr7:38081787..38084497,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs536376994 | chr7:38071264-38071265 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs149401142 | chr7:38071339-38071340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs189757848 | chr7:38071340-38071341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182370566 | chr7:38071344-38071345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566764511 | chr7:38071346-38071347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs538844522 | chr7:38071375-38071376 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566344802 | chr7:38071412-38071413 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs17171268 | chr7:38071457-38071458 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs575860977 | chr7:38071458-38071459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs375319233 | chr7:38071544-38071545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71734555 | chr7:38071553-38071554 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs367921529 | chr7:38071559-38071560 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs554943779 | chr7:38071574-38071575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs187041954 | chr7:38071581-38071582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs540367805 | chr7:38071599-38071600 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192327093 | chr7:38071626-38071627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs370613477 | chr7:38071673-38071674 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576398710 | chr7:38071681-38071682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs138664665 | chr7:38071682-38071683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28427510 | chr7:38071710-38071711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183230932 | chr7:38071720-38071721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112963064 | chr7:38071723-38071724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1721396 | chr7:38071732-38071733 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs548442721 | chr7:38071751-38071752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368348952 | chr7:38071759-38071760 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs567357684 | chr7:38071820-38071821 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs150435910 | chr7:38071827-38071828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1717729 | chr7:38071829-38071830 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs192249467 | chr7:38071894-38071895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs76518393 | chr7:38071909-38071910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566628487 | chr7:38071914-38071915 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376241724 | chr7:38071994-38071995 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs538708997 | chr7:38072006-38072007 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7782762 | chr7:38072022-38072023 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs148890913 | chr7:38072039-38072040 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs140362942 | chr7:38072049-38072050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112410192 | chr7:38072086-38072087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538188677 | chr7:38072101-38072102 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs540043215 | chr7:38072116-38072117 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12672796 | chr7:38072195-38072196 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs182466786 | chr7:38072200-38072201 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs533770278 | chr7:38072222-38072223 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs372439473 | chr7:38072274-38072275 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs553762253 | chr7:38072299-38072300 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs577028902 | chr7:38072308-38072309 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs545853430 | chr7:38072396-38072397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs562569384 | chr7:38072419-38072420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374952403 | chr7:38072427-38072428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541799687 | chr7:38072467-38072468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs115240485 | chr7:38072483-38072484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Cancer | 21637783 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Breast cancer | 16397240 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 21785460 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Williams-beuren syndrome | 22470819 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Acute myeloid leukemia | 17237825 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Colorectal cancer | 19455253 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Sezary syndrome | 18413736 | CNVD |
Gastric cancer | 24379144 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Williams Syndrome | 20824207 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:38070600-38071400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
2 | chr7:38070600-38072000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
3 | chr7:38070800-38071400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr7:38070800-38071400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr7:38070800-38071400 | Enhancers | Stomach Mucosa | stomach |
6 | chr7:38071200-38072600 | Enhancers | Ovary | ovary |
7 | chr7:38072000-38073800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
8 | chr7:38073800-38074000 | Enhancers | Rectal Mucosa Donor 31 | rectum |
9 | chr7:38073800-38074400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |